English  |  正體中文  |  简体中文  |  Items with full text/Total items : 58034/91575 (63%)
Visitors : 13720989      Online Users : 63
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library & TKU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://tkuir.lib.tku.edu.tw:8080/dspace/handle/987654321/117141


    Title: Bioprocessing shrimp shells to rat intestinal α- glucosidase inhibitor and its effect on reducing blood glucose in a mouse model
    Authors: VB, Nguyen;TH, Nguyen;AD, Nguyen;Le, T;YH, Kuo;SL, Wang
    Keywords: Shrimp shells;α-Glucosidase inhibitors;Anti-cancer;Diabetes;Process biochemistry
    Date: 2019
    Issue Date: 2019-09-26 12:10:59 (UTC+8)
    Publisher: Springers
    Abstract: The α-Glucosidase inhibitors (aGIs) from natural resources have been recognized
    as a safe and efficacious way to manage type 2 diabetes—an ongoing global health
    problem. The objective of this study was to synthesize aGIs from demineralized
    shrimp shell powder (deSSP), a low-cost fishery processing by-product, via microbial
    fermentation. Its effect on reducing plasma glucose in an ICR mouse model was
    then evaluated, and its other beneficial bioactivities investigated. Among the various
    marine chitinous materials, fermented deSSP (fdeSSP) via Paenibacillus conversion
    demonstrated potent inhibition against rat intestinal α-glucosidase that was
    comparable to acarbose, a commercial anti-diabetic drug, with max inhibition and
    IC50
    values 87% and 120 μg/mL, and 89% and 110 μg/mL, respectively. After optimization
    of the fermentation process, activity increased 1.52-fold (2500–3800 U/
    mL). By comparing the HPLC fingerprints and bioactivity of fermented and unfermented
    deSSP, it was confirmed that aGIs were produced as they were not present
    in the deSSP medium prior to fermentation. In animal tests, at a dose of 100 mg/kg
    bw, fdeSSP significantly reduced plasma glucose in ICR mice with no signs of diarrhea.
    The fdeSSP also demonstrated acceptable antioxidant activity (
    IC50 = 250 μg/
    mL) and potential anti-NO activity (70.08 μg/mL). Though not toxic to normal cells,
    fdeSSP reduced the viability of some cancer cells, including A549, Hep G2, MCF-7
    and WIDR with inhibition values of 78%, 71%, 45% and 35%, respectively. The
    results above suggest that fdeSSP may be a good candidate for development as a
    health food or drug, due to its potential hypoglycemic and added value bioactivities.
    Relation: Research on Chemical Intermediates 45(10), p.4829-4846
    DOI: 10.1007/s11164-019-03869-2
    Appears in Collections:[Graduate Institute & Department of Chemistry] Journal Article

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML63View/Open

    All items in 機構典藏 are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library & TKU Library IR teams. Copyright ©   - Feedback